Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-06-15

Clinical Trial Update: Becker Muscular Dystrophy - A Natural History Study to Predict Efficacy of Exon Skipping

View source ↗

Summary

A clinical trial update describing a natural history study in Becker muscular dystrophy to predict the efficacy of exon skipping. The current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Cooperative International Neuromuscular Research Group | Conditions: Becker Muscular Dystrophy | Status: UNKNOWN